These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 27811380)

  • 1. Exhaled breath profiling in patients with COPD and OSA overlap syndrome: a pilot study.
    Dragonieri S; Quaranta VN; Carratu P; Ranieri T; Resta O
    J Breath Res; 2016 Nov; 10(4):041001. PubMed ID: 27811380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exhaled volatile organic compounds analysis by e-nose can detect idiopathic pulmonary fibrosis.
    Dragonieri S; Scioscia G; Quaranta VN; Carratu P; Venuti MP; Falcone M; Carpagnano GE; Foschino Barbaro MP; Resta O; Lacedonia D
    J Breath Res; 2020 Jul; 14(4):047101. PubMed ID: 32320958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An electronic nose in the discrimination of obese patients with and without obstructive sleep apnoea.
    Dragonieri S; Porcelli F; Longobardi F; Carratù P; Aliani M; Ventura VA; Tutino M; Quaranta VN; Resta O; de Gennaro G
    J Breath Res; 2015 Apr; 9(2):026005. PubMed ID: 25891965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma.
    Fens N; Zwinderman AH; van der Schee MP; de Nijs SB; Dijkers E; Roldaan AC; Cheung D; Bel EH; Sterk PJ
    Am J Respir Crit Care Med; 2009 Dec; 180(11):1076-82. PubMed ID: 19713445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exhaled breath profiling by electronic nose enabled discrimination of allergic rhinitis and extrinsic asthma.
    Dragonieri S; Quaranta VN; Carratu P; Ranieri T; Resta O
    Biomarkers; 2019 Feb; 24(1):70-75. PubMed ID: 30074408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. External validation of exhaled breath profiling using an electronic nose in the discrimination of asthma with fixed airways obstruction and chronic obstructive pulmonary disease.
    Fens N; Roldaan AC; van der Schee MP; Boksem RJ; Zwinderman AH; Bel EH; Sterk PJ
    Clin Exp Allergy; 2011 Oct; 41(10):1371-8. PubMed ID: 21732998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD.
    Dragonieri S; Annema JT; Schot R; van der Schee MP; Spanevello A; Carratú P; Resta O; Rabe KF; Sterk PJ
    Lung Cancer; 2009 May; 64(2):166-70. PubMed ID: 18834643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrafast gas chromatography coupled to electronic nose to identify volatile biomarkers in exhaled breath from chronic obstructive pulmonary disease patients: A pilot study.
    Rodríguez-Aguilar M; Ramírez-García S; Ilizaliturri-Hernández C; Gómez-Gómez A; Van-Brussel E; Díaz-Barriga F; Medellín-Garibay S; Flores-Ramírez R
    Biomed Chromatogr; 2019 Dec; 33(12):e4684. PubMed ID: 31423612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evening and morning exhaled volatile compound patterns are different in obstructive sleep apnoea assessed with electronic nose.
    Kunos L; Bikov A; Lazar Z; Korosi BZ; Benedek P; Losonczy G; Horvath I
    Sleep Breath; 2015 Mar; 19(1):247-53. PubMed ID: 24840212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of airway bacterial colonization by an electronic nose in Chronic Obstructive Pulmonary Disease.
    Sibila O; Garcia-Bellmunt L; Giner J; Merino JL; Suarez-Cuartin G; Torrego A; Solanes I; Castillo D; Valera JL; Cosio BG; Plaza V; Agusti A
    Respir Med; 2014 Nov; 108(11):1608-14. PubMed ID: 25269711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease.
    Pizzini A; Filipiak W; Wille J; Ager C; Wiesenhofer H; Kubinec R; Blaško J; Tschurtschenthaler C; Mayhew CA; Weiss G; Bellmann-Weiler R
    J Breath Res; 2018 Mar; 12(3):036002. PubMed ID: 29295966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of exhaled volatile organic compounds analysis using electronic nose as index of COPD severity.
    Finamore P; Pedone C; Scarlata S; Di Paolo A; Grasso S; Santonico M; Pennazza G; Antonelli Incalzi R
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1441-1448. PubMed ID: 29750030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An electronic nose distinguishes exhaled breath of patients with Malignant Pleural Mesothelioma from controls.
    Dragonieri S; van der Schee MP; Massaro T; Schiavulli N; Brinkman P; Pinca A; Carratú P; Spanevello A; Resta O; Musti M; Sterk PJ
    Lung Cancer; 2012 Mar; 75(3):326-31. PubMed ID: 21924516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breath profiles by electronic nose correlate with systemic markers but not ozone response.
    Biller H; Holz O; Windt H; Koch W; Müller M; Jörres RA; Krug N; Hohlfeld JM
    Respir Med; 2011 Sep; 105(9):1352-63. PubMed ID: 21439804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of electronic nose technology with spirometry: validation of a new approach for exhaled breath analysis.
    de Vries R; Brinkman P; van der Schee MP; Fens N; Dijkers E; Bootsma SK; de Jongh FH; Sterk PJ
    J Breath Res; 2015 Oct; 9(4):046001. PubMed ID: 26469298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrimination between COPD patients with and without alpha 1-antitrypsin deficiency using an electronic nose.
    Hattesohl AD; Jörres RA; Dressel H; Schmid S; Vogelmeier C; Greulich T; Noeske S; Bals R; Koczulla AR
    Respirology; 2011 Nov; 16(8):1258-64. PubMed ID: 21883674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD.
    Gaida A; Holz O; Nell C; Schuchardt S; Lavae-Mokhtari B; Kruse L; Boas U; Langejuergen J; Allers M; Zimmermann S; Vogelmeier C; Koczulla AR; Hohlfeld JM
    J Breath Res; 2016 Apr; 10(2):026006. PubMed ID: 27082437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of age and gender on the profile of exhaled volatile organic compounds analyzed by an electronic nose.
    Dragonieri S; Quaranta VN; Carratu P; Ranieri T; Resta O
    J Bras Pneumol; 2016 Apr; 42(2):143-5. PubMed ID: 27167436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Influence of Smoking Status on Exhaled Breath Profiles in Asthma and COPD Patients.
    Principe S; van Bragt JJMH; Longo C; de Vries R; Sterk PJ; Scichilone N; Vijverberg SJH; Maitland-van der Zee AH
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33806279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breathing Rhythm Variations during Wash-In Do Not Influence Exhaled Volatile Organic Compound Profile Analyzed by an Electronic Nose.
    Dragonieri S; Quaranta VN; Carratù P; Ranieri T; Buonamico E; Carpagnano GE
    Molecules; 2021 May; 26(9):. PubMed ID: 34064506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.